Close Menu

People In The News

NEW YORK (GenomeWeb News) - Compugen said this week that Anat Cohen-Dayag and Martin Gerstel will serve as co-CEOs of the company. Cohen-Dayag started with the company in 2002, and she has served as VP for diagnostic biomarkers and drug targets. Before starting at Compugen, she was head of R&D at Mindsense Biosystems.

Gerstel began at Compugen in 1997 as chairman and was appointed president and CEO earlier this year. Before joining Compugen, Gerstel was co-chairman and CEO of ALZA Corporation and a director of the Pharmaceutical Research and Manufacturers of America.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.